Trial Profile
Planned phase I trial of IL-17E for the treatment of solid tumours.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 07 Dec 2012
Price :
$35
*
At a glance
- Drugs IL 17E (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2012 New trial record